OTC/Rx Ad Differentiation "Easy" For Nearly 80% Of Consumers - FDA Survey
This article was originally published in The Tan Sheet
Executive Summary
A strong majority of consumers are able to determine whether TV or print ads pertain to OTC or Rx drug products, according to FDA's survey, "Attitudes and Behaviors Associated with Direct-To-Consumer Promotion of Prescription Drugs."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning